<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00049803</url>
  </required_header>
  <id_info>
    <org_study_id>OMC-SXB-15</org_study_id>
    <nct_id>NCT00049803</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients</brief_title>
  <official_title>Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem (Sodium Oxybate) With Placebo for the Treatment of Narcolepsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orphan Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orphan Medical</source>
  <brief_summary>
    <textblock>
      The initial portion of the protocol involves discontinuing any medications for cataplexy that&#xD;
      the patient may be taking. Subsequently, the patient is prescribed a dose of oral solution of&#xD;
      study drug or placebo over a 10-11 week period. During the trial, narcolepsy symptoms will be&#xD;
      evaluated. Participants are allowed to continue using stimulant medications at constant doses&#xD;
      during the study. A total of 1 to 3 daytime visits in addition to 4 overnight visits to the&#xD;
      sleep center will be required to complete the study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2000</start_date>
  <completion_date>April 2004</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>200</enrollment>
  <condition>Narcolepsy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium oxybate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA&#xD;
&#xD;
          -  Have signed &amp; dated informed consent before beginning protocol procedures.&#xD;
&#xD;
          -  Willing &amp; able to complete entire trial as described in protocol.&#xD;
&#xD;
          -  16 years of age or older.&#xD;
&#xD;
          -  Have a history and presenting symptoms of excessive daytime sleepiness.&#xD;
&#xD;
          -  Have a history of cataplexy localizable to a specific muscle group(s) or part(s) of&#xD;
             body during which the patient is lucid (not experiencing an inadvertent nap or micro&#xD;
             sleep).&#xD;
&#xD;
          -  Have valid PSG &amp; MSLT scores (collected during an overnight test) within last five&#xD;
             years and a current diagnosis of narcolepsy according to the following criteria&#xD;
             established by the American Sleep Disorders Association: (1) Recurrent daytime naps or&#xD;
             lapses into sleep occur almost daily for at least 3 months; (2) Sudden bilateral loss&#xD;
             of postural muscle tone occurs in association with intense emotion (cataplexy); (3)&#xD;
             Polysomnography demonstrates one or more of the following: (a) Sleep latency less than&#xD;
             10 minutes; (b) REM sleep latency less than 20 minutes; (c) An MSLT that demonstrates&#xD;
             a mean sleep latency of less than 5 minutes; (d) Two or more sleep-onset REM periods&#xD;
&#xD;
          -  Females who are surgically sterile, two years post-menopausal, or if of child-bearing&#xD;
             potential, using a medically accepted method of birth control and agree to continue&#xD;
             use of this method for the duration of the trial.&#xD;
&#xD;
          -  In the opinion of the investigator, have adequate support for the duration of trial to&#xD;
             include transportation to and from trial site. In addition, if in the investigator's&#xD;
             assessment it is clinically indicated, the patient is willing to not operate a car or&#xD;
             heavy machinery for the duration of the trial or for as long as the investigator deems&#xD;
             clinically indicated.&#xD;
&#xD;
        EXCLUSION CRITERIA&#xD;
&#xD;
          -  Received gamma-hydroxybutyrate in the last 30 days.&#xD;
&#xD;
          -  Have taken any investigational therapy within 30-day period prior to initial screening&#xD;
             visit for this trial.&#xD;
&#xD;
          -  Patients taking fluoxetine (Prozac).&#xD;
&#xD;
          -  Have been diagnosed with sleep apnea syndrome, defined as an Apnea Index &gt; 10 per hour&#xD;
             or an Apnea Hypopnea Index greater than 15 per hour, or have any other cause of&#xD;
             daytime sleepiness, and have any other disorder(s) that can be considered a primary&#xD;
             cause of excessive daytime sleepiness.&#xD;
&#xD;
          -  Taking hypnotics, tranquilizers, antihistamines (except for non-sedating&#xD;
             antihistamines), benzodiazepines or clonidine at the start of the baseline period.&#xD;
             Patients taking anticonvulsants are not eligible to participate even if willing to&#xD;
             washout anticonvulsants for the trial.&#xD;
&#xD;
          -  Experiencing unstable cardiovascular, endocrine, neoplastic (excluding localized basal&#xD;
             cell carcinoma), gastrointestinal, hematologic, hepatic, immunologic, metabolic,&#xD;
             neurological (other than narcolepsy/cataplexy), pulmonary, and/or renal disease which&#xD;
             would place the patient at risk during the trial or compromise objectives outlined in&#xD;
             the protocol.&#xD;
&#xD;
          -  Have psychiatric disorders, major affective or psychotic disorders, or other problems&#xD;
             that, in the investigator's opinion, would preclude the patient's participation and&#xD;
             completion of this trial or compromise reliable representation of subjective symptoms.&#xD;
&#xD;
          -  Have current or recent (within one year) history of a substance use disorder including&#xD;
             alcohol abuse as defined by DSM-IV.&#xD;
&#xD;
          -  Serum creatinine greater than 2.0 mg/dL, abnormal liver function tests (SGOT [AST] or&#xD;
             SGPT [ALT] more than twice the upper limit of normal), or elevated serum bilirubin&#xD;
             (more than 1.5 times upper limit of normal), or pre-trial ECG results demonstrating&#xD;
             clinically significant arrhythmias, greater than a first degree AV block or a history&#xD;
             of myocardial infarction within last six months.&#xD;
&#xD;
          -  Have an occupation that requires variable shift work or routine night shift.&#xD;
&#xD;
          -  Have a clinically significant history of seizure disorder, a history of clinically&#xD;
             significant head trauma (i.e., concussion resulting in clinically significant loss of&#xD;
             consciousness) or past invasive intracranial surgery, and are taking anticonvulsant&#xD;
             medications.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Houghton, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Orphan Medical</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Harry N Cook, MBA, RPh</last_name>
    <role>Study Director</role>
    <affiliation>Orphan Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sleep Disorders Center of Alabama, Inc.</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Sleep Medicine Services</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037-1205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford Sleep Disorders Clinic</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Petersburg Sleep Disorders Center</name>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <zip>33707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Disorders Center of Georgia</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Disorders Center--Division of Neurology</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peoria Pulmonary Associates, Ltd.</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61603</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Center for Sleep and Wake Disorders/Midwest Neurology</name>
      <address>
        <city>Danville</city>
        <state>Indiana</state>
        <zip>46122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fort Wayne Neurological Center</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fort Wayne Neurological Center</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chest Medicine Associates DBA/Sleep Medicine Specialists</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40217</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LSU Health Science Center</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Sleep and Wake Disorders</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Sleep Diagnostics</name>
      <address>
        <city>Newton</city>
        <state>Massachusetts</state>
        <zip>02459</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University -- Sleep Medicine Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep/Wake Center 7N2 -- Bellevue Hospital Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Sleep Center - Community General Hospital</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Raleigh Neurology Associates</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Carolina Neurology &amp; Sleep</name>
      <address>
        <city>Salisbury</city>
        <state>North Carolina</state>
        <zip>28144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CSC Research -- Grove City Sleep Diagnostic Center</name>
      <address>
        <city>Grove City</city>
        <state>Ohio</state>
        <zip>43123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwest Cleveland Sleep Center</name>
      <address>
        <city>Middleburg Heights</city>
        <state>Ohio</state>
        <zip>44130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lynn Health Science Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Pharmaceutical Trials, Inc.</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital - Division of Pulmonary, Sleep and Critical Care Medicine</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charleston Pulmonary Associates PA</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Low Country Lung and Critical Care PA</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29406-7108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Palmetto Baptist Medical Center Sleep Disorders Center</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charleston Pulmonary Associates PA</name>
      <address>
        <city>Mount Pleasant</city>
        <state>South Carolina</state>
        <zip>29464</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Medicine Assoc PLLC -- Summit Medical Center</name>
      <address>
        <city>Hermitage</city>
        <state>Tennessee</state>
        <zip>37076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Houston Sleep Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Medicine Associates of Texas</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Disorders Center -- Eastern Virginia Medical School -- Sentara General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VCU Health System MCV Hospitals - Sleep Disorders Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Sleep Medicine Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Canadian Sleep Institute</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2X2A8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vancouver Hospital -- Sleep Disorders Clinic</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6T2B5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John Regional Hospital -- Somnology Program</name>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <zip>E2L4L2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital Sleep Centre -- Ottawa Hospital -- Civic Campus -- Sleep Laboratory</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4E9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Sleep Disorders Clinic of the Centre for Sleep and Chronobiology</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 3A9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brain &amp; Sleep Diagnostic Center</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M8X2W2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Disorder Centre -- Hopital du Sacre-Coeur</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4J1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurologische Poliklinik - Universitats Spital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>CH-8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep. 2002 Feb 1;25(1):42-9.</citation>
    <PMID>11833860</PMID>
  </reference>
  <reference>
    <citation>Scrima L, Hartman PG, Johnson FH Jr, Thomas EE, Hiller FC. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study. Sleep. 1990 Dec;13(6):479-90.</citation>
    <PMID>2281247</PMID>
  </reference>
  <reference>
    <citation>Lammers GJ, Arends J, Declerck AC, Ferrari MD, Schouwink G, Troost J. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep. 1993 Apr;16(3):216-20.</citation>
    <PMID>8506453</PMID>
  </reference>
  <reference>
    <citation>A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep. 2003 Feb 1;26(1):31-5.</citation>
    <PMID>12627729</PMID>
  </reference>
  <verification_date>July 2004</verification_date>
  <study_first_submitted>November 13, 2002</study_first_submitted>
  <study_first_submitted_qc>November 14, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2002</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <keyword>Narcolepsy</keyword>
  <keyword>Sodium Oxybate</keyword>
  <keyword>Cataplexy</keyword>
  <keyword>Excessive Daytime Sleepiness</keyword>
  <keyword>GHB</keyword>
  <keyword>Gamma Hydroxybutyric Acid</keyword>
  <keyword>Orphan Medical</keyword>
  <keyword>Orphan Drug</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Narcolepsy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sodium Oxybate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

